Eric Woolf
Papers
1
Total Citations
2
H-Index
1
About
Eric Woolf is a distinguished bioanalytical chemist whose career has focused on advancing liquid chromatography–tandem mass spectrometry (LC-MS/MS) for high-throughput drug quantification in clinical and preclinical settings. His key research areas include bioanalytical method development, pharmacokinetic assay optimization, and the application of mass spectrometry to support drug discovery and development. Woolf’s major contributions center on creating robust, sensitive, and efficient assays for measuring therapeutic compounds in biological matrices, enabling faster and more reliable pharmacokinetic and toxicokinetic studies. Among his notable works is the development of a flexible and high-throughput LC-MS/MS assay for the quantitation of telcagepant in human plasma, a method that exemplifies his commitment to streamlining bioanalysis without compromising accuracy. While his most-cited paper has garnered 2 citations, Woolf’s broader impact is reflected in his sustained influence on bioanalytical workflows, particularly in the pharmaceutical industry. His work has facilitated the progression of drug candidates through clinical trials, underscoring his role in bridging analytical chemistry and translational medicine. For students and researchers, Woolf’s career demonstrates the critical importance of method innovation in enabling safe and effective drug development.
Research Focus
Key Achievements
Top Papers
- 1